Investment

Details

Screening Program
Project Completed
 
  • RFP Year
    2014
  • Awarded Amount
    $137,883
  • Disease
    Malaria
  • Intervention
    Drug
  • Development Stage
    Hit Identification
  • Collaboration Partners
    Sumitomo Dainippon Pharma Co., Ltd. ,  Medicines for Malaria Venture (MMV)